Company’s Ovarian Assay is the First in a Series of Planned Indications Using EV3D Technology Platform Optimized for Solid Tumors GREENVILLE, S.C.– August 1, 2019 – KIYATEC, Inc. today announces …
Latest News
NEXT’s Christy Ashkettle tapped for Leadership Greenville
(Greenville, SC)- The Greenville Chamber’s Leadership Greenville program has accepted 62 participants for its 46th class. Participants were selected based on a thorough application process including …
Continue Reading about NEXT’s Christy Ashkettle tapped for Leadership Greenville →
NEXT Fellows Adds New Intern to Inaugural Summer Program
In May this year, NEXT Kicked off their Summer Internship Program. You heard from Collin Edwards previously and this month, we are happy to welcome Andrej Suttles. A Furman Grad and entrepreneur at …
Continue Reading about NEXT Fellows Adds New Intern to Inaugural Summer Program →
Labcorp-backed Medtech Startup Predicts Outcome Of Cancer Therapies On Tumors
On average, it takes about eight years from the time a potential cancer drug enters clinical trials until it’s approved, according to the American Cancer Society. But not every drug that’s approved …
VentureSouth invests with two Greenville startups
VentureSouth recently conducted investment rounds for two startups based in Greenville. These startups are the 22nd and 23rd companies that VentureSouth has invested in and supported within …
Continue Reading about VentureSouth invests with two Greenville startups →
Press Release: ChartSpan Lands $15M Investment & NEXT Announces New Venture Capital Office
Contact: Leah Shaffer Director of Marketing, ChartSpan (540) 424-9350 leah.shaffer@chartspan.com BIP Capital Plants Roots in Upstate South Carolina Following Large Investment in ChartSpan …
